The relation between liver histopathology and GGT levels in viral hepatitis: More important in hepatitis B

Turkish Journal of Gastroenterology

Volumn 25, Issue 4, 2014, Pages 411-415

  Eminler, Ahmet Tarik ^a   Irak, Kader ^a   Ayyildiz, Talat ^a   Keskin, Murat ^a   Kiyici, Murat ^a   Gurel, Selim ^a   Gulten, Macit ^a   Dolar, Enver ^a   Nak, Selim Giray ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

GGT; Liver pathology; Viral hepatitis

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; VIRUS DNA; VIRUS RNA;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEPATITIS B; HEPATITIS C; HISTOLOGICAL ACTIVITY INDEX; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ISHAK SCORE; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PATIENT REFERRAL; ADOLESCENT; BIOPSY; BLOOD; CHRONIC HEPATITIS C; ENZYMOLOGY; INTERNATIONAL NORMALIZED RATIO; LIVER; LIVER CIRRHOSIS; MIDDLE AGED; PATHOLOGY; SEVERITY OF ILLNESS INDEX; THROMBOCYTE COUNT; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASES; BIOPSY; DNA, VIRAL; GAMMA-GLUTAMYLTRANSFERASE; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; INTERNATIONAL NORMALIZED RATIO; LIVER; LIVER CIRRHOSIS; MIDDLE AGED; PLATELET COUNT; RNA, VIRAL; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84908149154     PISSN: 13004948     EISSN: 21485607     Source Type: Journal    
DOI: 10.5152/tjg.2014.3693     Document Type: Article

References (19)

1. Ersöz G, Karasu Z, Akarca US, Yüce G, Ilter T, Batur Y. Does blood biochemistry reflect liver histology in chronic viral hepatitis? Turkiye Klinikleri J Gastroenterohepatol 1998;9(2):80-4.
2. Ter Borg F, Ten Kate FJ, Cuypers HT, et al. Relation between laboratory test results and histological hepatitis activity in individuals positive for hepatitis B surface antigen and antibodies to hepatitis B e antigen. Lancet 1998; 351: 1914-8. [CrossRef].
3. Akkaya O, Kiyici M, Yilmaz Y, Ulukaya E, Yerci O. Clinical significance of activity of ALT enzyme in patients with hepatitis C virus. World J Gastroenterol 2007; 13: 5481-5. [CrossRef].
4. Giustina G, Fattovich G, De Paoli M, et al. Serum procollagen type III peptide in chronic hepatitis B. Relationship to disease activity and response to interferon-alpha therapy. Int J Clin Lab Res 1996; 26: 33-6. [CrossRef].
5. Pontinha N, Pessegueiro H, Barros H. Serum hyaluronan as a marker of liver fibrosis in asymptomatic chronic viral hepatitis B. Scand J Clin Lab Invest 1999; 59: 343-47. [CrossRef].
6. Murawaki Y, Ikuta Y, Idobe Y. Serum matrix metalloproteinase-1 in patients with chronic viral hepatitis. J Gastroenterol Hepatol 1999; 14: 138-145. [CrossRef].
7. Murawaki Y, Nishimura Y, Ikuta Y. Plasma transforming growth factor- beta 1 concentrations in patients with chronic viral hepatitis. J Gastroenterol Hepatol 1998; 13: 680-4. [CrossRef].
8. Aygün C, Gözel N, Demirel U. Kronik viral hepatit B tanisi olan hastalarda serum GGT düzeyi ile karaciger fibrozu iliskisi. Firat Medical Journal 2010; 15: 74-8.
9. Whitfield JB. Gamma glutamyl transferase. Crit Rev Clin Lab Sci 2001; 38: 263-355. [CrossRef].
10. Vardar R, Vardar E, Demiri S, et al. There any non-invasive marker replace the needle liver biopsy predictive for liver fibrosis, in patients with chronic hepatitis? Hepatogastroenterology 2009; 56: 1459-65.
11. Abdo AA. Laboratory predictors of advanced fibrosis in Saudi patients with chronic hepatitis B and C. Saudi J Gastroenterol 2006; 12: 135-8. [CrossRef].
12. Mossong J, Bill S, Hawotte K. Predicting significant fibrosis in hepatitis C patients in Luxembourg using serological markers. Bull Soc Sci Med Grand Duche Luxemb 2011; 19-30.
13. Imbert-Bismut F, Ratziu V, Pieroni L, et al. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: A prospective study. Lancet 2001; 357: 1069-75. [CrossRef].
14. Forns X, Ampurdanès S, Llovet JM, et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 2002; 36: 986-92. [CrossRef].
15. Silva IS, Ferraz ML, Perez RM, Lanzoni VP, Figueiredo VM, Silva AE. Role of gamma-glutamyl transferase activity in patients with chronic hepatitis C virus infection. J Gastroenterol Hepatol 2004; 19: 314-8. [CrossRef].
16. Hwang SJ, Luo JC, Lai CR, et al. Clinical, virologic and pathologic significance of elevated serum gamma-glutamyl transpeptidase in patients with chronic hepatitis C. J Chin Med Assoc 2000; 63: 527-35.
17. Myers RP, Tainturier MH, Ratziu V, et al. Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B. J Hepatol 2003; 39: 222-30. [CrossRef].
18. Zhou K, Gao CF, Zhao YP, et al. Simpler score of routine laboratory tests predicts liver fibrosis in patients with chronic hepatitis B. J Gastroenterol Hepatol 2010; 25: 1569-77. [CrossRef].
19. Xian YC, Yang JY, Xu R, Huang CJ, Wu LL. [Clinical significance of serum glutamyl transpeptidase in chronic hepatitis B]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 2007; 21: 383-5 (Abstract).